Valuation: SOPHiA GENETICS SA

Market Cap 626M 559M 516M 468M 875M 59.4B 890M 6.21B 2.46B 31.12B 2.35B 2.3B 98.11B P/E 2026 *
-7.84x
P/E 2027 * -11.7x
Enterprise Value 626M 559M 516M 468M 875M 59.4B 890M 6.21B 2.46B 31.12B 2.35B 2.3B 98.11B EV / Sales 2026 *
6.57x
EV / Sales 2027 * 5.27x
Free-Float
88.99%
Yield 2026 *
-
Yield 2027 * -
1 day+4.26%
1 week+9.21%
Current month-12.29%
1 month-11.02%
3 months+28.50%
6 months+51.55%
Current year+57.39%
1 week 6.39
Extreme 6.39
7.43
1 month 6.39
Extreme 6.39
8.73
Current year 4
Extreme 4.005
8.98
1 year 3.83
Extreme 3.83
8.98
3 years 2.58
Extreme 2.58
8.98
5 years 1.68
Extreme 1.685
16.93
10 years 1.68
Extreme 1.685
19.8
Manager TitleAgeSince
Chief Executive Officer 46 2026-06-30
Director of Finance/CFO 64 2024-11-04
Chief Tech/Sci/R&D Officer - 2022-01-09
Director TitleAgeSince
Director/Board Member 74 2020-05-31
Director/Board Member 57 2014-05-31
Director/Board Member 46 2026-06-21
Date Insider Type Main position Quantity % Market Cap. Importance
10/13/26 Sell

Chief Technology Officer

-4,000 0.0047%
10/12/26 Sell

Chief Technology Officer

-5,000 0.0059%
10/12/26 Sell

Founder

-8,500 0.0100%
Change 5-day change 1-year change 3-year change Capi.($)
+4.26%+9.21%+72.94%+116.81% 626M
-0.40%-2.34%+17.70%+47.04% 249B
+0.33%+0.64%+3.36%+17.10% 162B
+1.90%+6.00%-17.24%+63.05% 157B
-0.70%+2.93%-54.81%-10.34% 66.22B
+0.15%+4.09%+10.25%+63.82% 52.3B
+0.24%+0.99%-15.49%-12.11% 52.18B
-1.13%+2.85%+17.04%+26.36% 51.34B
-0.47%+0.06%+16.92%+63.83% 48.79B
-0.42%+3.83%+26.19%+82.07% 44.57B
Average +0.38%+2.96%+7.69%+45.76% 88.41B
Weighted average by Cap. +0.15%+1.51%+1.43%+39.13%

Financials

2026 *2027 *
Net sales 95.23M 85.04M 78.56M 71.2M 133M 9.04B 135M 945M 374M 4.74B 357M 350M 14.93B 119M 106M 97.91M 88.73M 166M 11.27B 169M 1.18B 466M 5.9B 445M 436M 18.61B
Net income -72.06M -64.35M -59.45M -53.87M -101M -6.84B -102M -715M -283M -3.58B -270M -265M -11.3B -48.53M -43.34M -40.03M -36.28M -67.88M -4.61B -69M -482M -191M -2.41B -182M -178M -7.61B
Net Debt - -
Projected Income Statement - Annual - SOPHiA GENETICS SA
Logo SOPHiA GENETICS SA
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Employees
415
Date Price Change Volume
26-10-23 US$7.350 +4.26% 455,636
26-10-22 US$7.050 -4.08% 353,203
26-10-21 US$7.350 +6.06% 591,930
26-10-20 US$6.930 +6.78% 639,613
26-10-19 US$6.490 -3.57% 510,913
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - SOPHiA GENETICS SA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
7.350USD
Average target price
9.750USD
Spread / Average Target
+32.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - SOPHiA GENETICS SA
  1. Stock Market
  2. Stocks
  3. SOPH Stock